ULTRACAINE 20MG/ML VIAL 50 ML

INDICATION FOR PRODUCTION OF LOCAL OR REGIONAL ANESTHESIA BY INFILTRATION TECHNIQUES SUCH AS PERCUTANEOUS INJECTION AND INTRAVENOUS REGIONAL ANESTHESIA BY PERIPHERAL NERVE BLOCK TECHNIQUES SUCH AS BRACHIAL PLEXUS AND INTERCOSTAL AND BY CENTRAL NEURAL TECHNIQUES SUCH AS LUMBAR AND CAUDAL EPIDURAL BLOCKS. MECHANISM OF ACTION LIDOCAINE STABILIZES THE NEURONAL MEMBRANE BY INHIBITING THE IONIC FLUXES REQUIRED FOR THE INITIATION AND CONDUCTION OF IMPULSES THEREBY EFFECTING LOCAL ANESTHETIC ACTION. LIDOCAINE ALTERS SIGNAL CONDUCTION IN NEURONS BY BLOCKING THE FAST VOLTAGE GATED SODIUM (NA+) CHANNELS IN THE NEURONAL CELL MEMBRANE THAT ARE RESPONSIBLE FOR SIGNAL PROPAGATION. WITH SUFFICIENT BLOCKAGE THE MEMBRANE OF THE POSTSYNAPTIC NEURON WILL NOT DEPOLARIZE AND WILL THUS FAIL TO TRANSMIT AN ACTION POTENTIAL. THIS CREATES THE ANAESTHETIC EFFECT BY NOT MERELY PREVENTING PAIN SIGNALS FROM PROPAGATING TO THE BRAIN BUT BY ABORTING THEIR BIRTH IN THE FIRST PLACE.